New pill aims to tame Huntington's: 400-Patient trial underway
Disease control
Recruiting now
This study tests an oral medication called SKY-0515 in 400 adults aged 25 and older with Huntington's disease. The goal is to see if the drug can lower harmful proteins and improve movement, thinking, and daily function. Participants are randomly assigned to receive either the dr…
Phase: PHASE2, PHASE3 • Sponsor: Skyhawk Therapeutics, Inc. • Aim: Disease control
Last updated May 14, 2026 12:04 UTC